esophagitis
Information
- Disease name
- esophagitis
- Disease ID
- DOID:11963
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03835663 | Active, not recruiting | The Bacterial Composition of the Stomach in Reflux Disease | June 4, 2018 | December 31, 2024 | |
| NCT00123630 | Completed | Phase 2 | A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab | November 2005 | January 2010 |
| NCT00123656 | Completed | Phase 2 | Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis | August 2004 | December 2006 |
| NCT00133770 | Completed | Phase 4 | Intravenous (IV) Pantoprazole in Erosive Esophagitis | July 2004 | March 2007 |
| NCT00175045 | Completed | Phase 2 | Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis | June 2003 | October 2003 |
| NCT00195208 | Completed | Phase 3 | Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis | June 2005 | November 2005 |
| NCT00256529 | Completed | Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia | November 2005 | February 2012 | |
| NCT00272818 | Completed | Study to Identify Non-Invasive Markers of Gastrointestinal Allergy | September 2004 | December 2008 | |
| NCT00284908 | Completed | Phase 1 | Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers | September 2006 | November 2006 |
| NCT00471094 | Completed | Phase 2 | Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis | May 2007 | October 2007 |
| NCT00523354 | Completed | Phase 2 | Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis | August 2007 | October 2007 |
| NCT00579410 | Completed | Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule | May 2004 | October 2009 | |
| NCT00677378 | Completed | Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain | December 2006 | October 2015 | |
| NCT00081315 | Completed | Phase 2 | Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer | November 2003 | August 2006 |
| NCT00842387 | Completed | Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD) | January 2009 | December 2009 | |
| NCT00872755 | Completed | Phase 4 | Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) | January 2002 | December 2008 |
| NCT01262560 | Completed | Phase 2 | Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer | February 2012 | November 2014 |
| NCT01322633 | Completed | Risk of Cancer Among Pantoprazole Users | July 2004 | March 2013 | |
| NCT01323803 | Completed | Eosinophilic Esophagitis Databank | April 2011 | February 2016 | |
| NCT01556919 | Completed | Esophageal Monitoring Device for Assessing Mucosal Impedance | March 2012 | July 23, 2021 | |
| NCT01733810 | Completed | N/A | The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis | February 1, 2013 | July 31, 2019 |
| NCT02100189 | Completed | N/A | Esophageal Cytology With FISH in Detecting Esophageal Cancer | February 2014 | December 2015 |
| NCT03228147 | Completed | N/A | Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment | July 25, 2017 | October 31, 2017 |
| NCT05129670 | Completed | N/A | Clinical Investigation to Assess the Acid Neutralisation Activity of a Calcite Chewing Gum | June 1, 2022 | May 22, 2023 |
| NCT03853772 | Enrolling by invitation | The Johns Hopkins Heartburn Center Registry | April 27, 2019 | December 2025 | |
| NCT05604261 | Not yet recruiting | Phase 2 | A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis | December 2022 | March 2024 |
| NCT04821310 | Recruiting | Phase 2 | Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years | January 13, 2022 | December 9, 2027 |
| NCT05326113 | Recruiting | N/A | The Effect of Physiotherapy on Post POEM Reflux | October 31, 2021 | January 18, 2025 |
| NCT01696734 | Recruiting | Phase 3 | Domperidone in Treating Patients With Gastrointestinal Disorders | October 23, 2012 | October 31, 2025 |
| NCT06392971 | Recruiting | Phase 2 | Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis | January 15, 2023 | April 15, 2026 |
| NCT03619408 | Recruiting | Management of Esophagitis Following Repair of Esophageal Atresia | February 1, 2019 | July 2025 | |
| NCT05109819 | Recruiting | N/A | Esophagus-sparing Radiotherapy for Metastatic Spinal Cord Compression. | May 20, 2021 | May 2024 |
| NCT04225026 | Terminated | Phase 2 | Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer | December 19, 2019 | March 27, 2022 |
| NCT02575391 | Terminated | Phase 1/Phase 2 | The Effects of Whole Food Intervention on Mucositis in Patients Treated for Thoracic Cancer | October 2009 | September 2012 |
| NCT00761254 | Terminated | N/A | Domperidone for Relief of Gastrointestinal Disorders | August 2008 | September 2012 |
| NCT05004155 | Unknown status | Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population | June 1, 2021 | December 31, 2022 | |
| NCT04252144 | Unknown status | N/A | Study of Dietary Patterns and Food Diversity in Russian GERD Patients | January 30, 2020 | December 31, 2023 |
| NCT00216788 | Unknown status | Phase 1 | The Effect of Nexium on Transmucosal Esophageal Leak | January 2006 | January 2006 |
| NCT02577393 | Unknown status | Phase 2 | Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy | April 2015 | August 2022 |
| NCT01824199 | Withdrawn | Early Phase 1 | CYP2C19 Genotype Predictor of Gastric Acid Suppression | March 2013 | November 2016 |
- Disase is a (Disease Ontology)
- DOID:6050
- Cross Reference ID (Disease Ontology)
- ICD10CM:K20
- Cross Reference ID (Disease Ontology)
- ICD9CM:530.1
- Cross Reference ID (Disease Ontology)
- MESH:D004941
- Cross Reference ID (Disease Ontology)
- NCI:C9224
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155673008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0014868
- Exact Synonym (Disease Ontology)
- acute esophagitis
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100633
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004941